Correction To: The Atypical RhoGTPase RhoE/Rnd3 Is a Key Molecule to Acquire a Neuroprotective Phenotype in Microglia

Journal of Neuroinflammation - United Kingdom
doi 10.1186/s12974-019-1416-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

NGF Steers Microglia Toward a Neuroprotective Phenotype

GLIA
Molecular NeuroscienceNeurologyCellular
2018English

Transformation From a Neuroprotective to a Neurotoxic Microglial Phenotype in a Mouse Model of ALS

Experimental Neurology
Developmental NeuroscienceNeurology
2012English

Correction To: KRAS Status Is Related to Histological Phenotype in Gastric Cancer: Results From a Large Multicentre Study

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Cyclic AMP Is a Key Regulator of M1 to M2a Phenotypic Conversion of Microglia in the Presence of Th2 Cytokines

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2016English

Is Altered Adrenal Steroid Biosynthesis a Key Intermediate Phenotype in Hypertension?

Hypertension
Internal Medicine
2003English

CD48 Is a Key Molecule of Immunomodulation Affecting Prognosis in Glioma

OncoTargets and Therapy
OncologyPharmacology
2019English

Primary Breast Cancer Stem-Like Cells Metastasise to Bone, Switch Phenotype and Acquire a Bone Tropism Signature

British Journal of Cancer
Cancer ResearchOncology
2013English

P75NTR Ectodomain Is a Physiological Neuroprotective Molecule Against Amyloid-Beta Toxicity in the Brain of Alzheimer’s Disease

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2015English

Correction To: Dendrimer-Mediated Delivery of N-Acetyl Cysteine to Microglia in a Mouse Model of Rett Syndrome

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy